-Reuters
These Analysts Lower Their Forecasts On Thermo Fisher After Q3 Results
Thermo Fisher Scientific Inc. (NYSE: TMO) reported mixed third-quarter financial results and lowered its FY23 guidance.
Related Posts
Why Alzheimers-Drug Developer Cassava Sciences Stock Is Trending
The top-line results showed no decline in cognition scores in patients with mild Alzheimer's disease who received simufilam continuously for 24 months. "We're fighting Alzheimer's disease by testing simufilam, a new type of drug that has a completely different mechanism of action from monoclonal antibody drug treatments," said Remi Barbier, CEO of Cassava.
‘TODAY at 1 PM in NYC: Striking Uber drivers to rally outside of Uber’s Headquarters’ – New York Taxi Workers Alliance
https://myemail.constantcontact.com/TODAY-at-1-PM-in-NYC--Striking-Uber-drivers-to-rally-o[…]-s-Headquarters.html?soid=1101912670699&aid=OfUmk-KCcnY
UPDATE: Geico Is Paying For Tesla Repairs At Arizona Service Centers, Automaker Says
Tesla Inc (NASDAQ: TSLA) electric vehicles insured by Geico are being repaired at the automaker's service centers in the Phoenix, Arizona area, according to the automaker.